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PURPOSE. The purpose of this study was to compare imaging of choroidal neovascularization
(CNV) using swept-source (SS) and spectral-domain (SD) optical coherence tomography
angiography (OCTA).
METHODS. Optical coherence tomography angiography was performed using a 100-kHz SS-
OCT instrument and a 68-kHz SD-OCTA instrument (Carl Zeiss Meditec, Inc.). Both 3 3 3- and
6 3 6-mm2 scans were obtained on both instruments. The 3 3 3-mm2 SS-OCTA scans
consisted of 300 A-scans per B-scan at 300 B-scan positions, and the SD-OCTA scans consisted
of 245 A-scans at 245 B-scan positions. The 6 3 6-mm2 SS-OCTA scans consisted of 420 A-
scans per B-scan at 420 B-scan positions, and the SD-OCTA scans consisted of 350 A-scans and
350 B-scan positions. B-scans were repeated four times at each position in the 3 3 3-mm2
scans and twice in the 6 3 6-mm2 scans. Choroidal neovascularization was excluded if not
fully contained within the 3 3 3-mm2 scans. The same algorithm was used to detect CNV on
both instruments. Two graders outlined the CNV, and the lesion areas were compared
between instruments.
RESULTS. Twenty-seven consecutive eyes from 23 patients were analyzed. For the 3 3 3-mm2
scans, the mean lesion areas for the SS-OCTA and SD-OCTA instruments were 1.17 and 1.01
mm2, respectively (P ¼ 0.047). For the 6 3 6-mm2 scans, the mean lesion areas for the SS-
OCTA and SD-OCTA instruments were 1.24 and 0.74 mm2 (P ¼ 0.003).
CONCLUSIONS. The areas of CNV tended to be larger when imaged with SS-OCTA than with SD-
OCTA, and this difference was greater for the 6 3 6-mm2 scans.
Keywords: optical coherence tomography angiography, OCTA, swept-source OCTA, spectral-
domain OCTA, neovascular AMD, choroidal neovascularization
Optical coherence tomography (OCT) has become avaluable imaging strategy for diagnosing and following
patients with neovascular AMD (nvAMD).1 Until recently, OCT
imaging could only identify some of the structural changes in
the macula associated with neovascularization, including
macular fluid and hyperreflective material in the retina, under
the retina, and under the RPE, but could not identify the
underlying vascular changes. With the development of OCT
angiography (OCTA), it is now possible to directly image the
neovascularization in the retina (type 3),2,3 under the retina and
above the RPE (type 2),4,5 and under the RPE (type 1).6,7 To
detect this vascular flow information, the OCTA algorithms
generate images based on the motion signal between repeated
OCT B-scans at the same position. This signal, which reflects
subtle differences between B-scans at the same position, is
mostly due to the movement of erythrocytes within blood
vessels.8 Although different OCTA instruments use different
hardware configurations and different motion contrasting
algorithms, the basic premise for the detection of blood flow
remains the same for all the different OCTA imaging strategies.
Both spectral-domain (SD) and swept-source OCTA instru-
ments have been used to detect choroidal neovascularization
(CNV).9,10 Both instruments use Fourier domain detection
techniques, but the SD-OCT instruments use a broadband near-
infrared superluminescent diode as a light source, currently
with a center wavelength of approximately 840 nm, with a
spectrometer as the detector, whereas the SS-OCT instruments
use a tunable swept laser, currently with a center wavelength of
approximately 1050 nm, with a single photodiode detector.11
One of the advantages of SS-OCTA imaging over SD-OCTA is the
faster scanning speed, which allows for denser scan patterns
and larger scan areas compared with SD-OCT scans for a given
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acquisition time. Additional advantages of the current SS-OCT
technology are its use of a longer wavelength and its reduced
sensitivity roll-off, resulting in enhanced light penetration
through the RPE, as well as better detection of signals from the
deeper layers. The longer wavelength is also safer for the eye
so a higher laser power can be used. The higher power
combined with the reduced sensitivity roll-off improves the
likelihood of detecting the inherently weaker signals from
deeper layers. Overall, these advantages should help the SS-
OCT system overcome the barrier of the RPE, resulting in
better detection of type 1 CNV compared with SD-OCTA
imaging.9 Although SD-OCTA imaging has been shown to
detect some CNV in nvAMD,2–7,9,12 there appear to be
limitations in the ability of SD-OCTA to detect neovasculariza-
tion under the RPE, as reported in cases when a CNV is known
to be present from dye-based angiographic imaging and
structural alterations, but SD-OCTA did not detect the
neovascular lesion.9,12,13 A recent report compared the ability
of both SD-OCTA and SS-OCTA to detect CNV, concluding that
SS-OCTA imaging appeared to be better than SD-OCTA in
detecting CNV. Possible explanations for why SS-OCTA was
better than SD-OCTA for the detection of CNV not only include
the longer wavelength of the swept source laser with its better
sensitivity roll-off and higher laser power, but also its higher
scanning speeds, which permitted higher A-scan and B-scan
densities and a greater number of B-scan repeats at each
position for a given acquisition time and scan area. Other
important differences between the two imaging techniques
included different image processing algorithms and the use of
different segmentation strategies to determine the full extent
of the neovascular lesions.9 Although we can’t control for the
laser wavelength, scanning speeds, sensitivity roll-off, or
scanning densities when comparing the two imaging strate-
gies, we can control for the algorithms used to process the
scans and the segmentation strategy used to visualize the CNV.
To compare the detection of CNV in nvAMD using both SD-
OCTA and SS-OCTA imaging, we performed a study with a
commercially available SD-OCTA instrument and a prototype
SS-OCTA instrument. Carl Zeiss Meditec, Inc. (Dublin, CA,
USA) manufactured both instruments. The output data from
both instruments were analyzed using the same segmentation
slabs, the same motion contrasting algorithm known as optical
microangiography (OMAGC), and the same retinal vascular
projection artifact removal algorithm.
PATIENTS AND METHODS
Patients were enrolled at the Bascom Palmer Eye Institute in a
prospective OCT imaging study. The Institutional Review
Board of the University of Miami Miller School of Medicine
approved the study, and an informed consent to participate in
the prospective OCT study was obtained from all patients. The
study was performed in accordance with the tenets of the
Declaration of Helsinki and compliant with the Health
Insurance Portability and Accountability Act of 1996.
Patients with the diagnosis of CNV secondary to AMD
previously identified by conventional SD-OCT structural
imaging or dye-based conventional angiography were scanned
on both the SD-OCTA and SS-OCTA instruments by the same
technician during the same imaging session. Spectral-domain
OCTA imaging was performed using of a Cirrus AngioPlex
device provided by Carl Zeiss Meditec, Inc. This instrument
had a center wavelength of 840 nm, a bandwidth of 90 nm, an
A-scan depth of 2.0 mm in tissue (1024 pixels), a full width at
half maximum (FWHM) axial resolution of ~5 lm in tissue, a
lateral resolution at the retinal surface estimated at ~15 lm,
and a scanning rate of 68,000 A-scans per second. All scans
were centered on the fovea, and FastTrac motion correction
software (Carl Zeiss Meditec, Inc.) was used while the images
were acquired. For the 33 3-mm2 SD-OCTA scans, each B-scan
contained 245 A-scans per B-scan along the fast x-axis, and
each B-scan was repeated four times at each position. There
were 245 B-scan positions along the slow y-axis. As a result, we
had a homogenous sampling grid with a separation of 12.2 lm.
For the 63 6-mm2 SD-OCTA scans, each B-scan contained 350
A-scans per B-scan along the fast x-axis, and each B-scan was
repeated two times at each position. There were 350 B-scan
positions along the slow y-axis. As a result, we had a
homogenous sampling grid with a separation of 17.1 lm.
Swept-source OCTA was performed using a prototype
provided by Carl Zeiss Meditec, Inc. This instrument is
characterized by a central wavelength of 1050 nm, a
bandwidth of 100 nm, an A-scan depth of 3.0 mm in tissue
(1536 pixels), a FWHM axial resolution of ~5 lm in tissue, a
lateral resolution at the retinal surface estimated at ~14 lm,
and a scanning rate of 100,000 A-scans per second. FastTrac
motion correction software was used while the images were
acquired. Scan protocols were similar to those described for
the SD-OCTA system but with an increased density of A-scans
per B-scan and B-scan positions. The 33 3-mm2 SS-OCTA scans
used 300 A-scans per B-scan repeated four times at each of the
300 B-scan positions. As a result, we had a homogenous
sampling grid with a separation of 10 lm. The 63 6-mm2 SS-
OCTA scans used 420 A-scans per B-scan repeated twice at
each of the 420 B-scan locations. As a result, we had a
homogenous sampling grid with a separation of 14.3 lm.
Visualization of the retinal and choroidal vasculature from
the volumetric datasets was achieved using a method known as
optical microangiography, based on the complex OCT signal
(OMAGC).8 The OMAGC algorithm incorporates variations in
both the intensity and phase information between sequential B-
scans at the same position to generate the flow information. En
face flow images were obtained using previously described
strategies for segmentation and removal of the decorrelation
projection artifacts.10,14–16 The same segmentation and image
processing strategies were applied to both the SD-OCTA and
SS-OCTA datasets. The segmentation boundaries for the slab
used in this study extended from the outer boundary of the
outer plexiform layer (OPL) to 8 lm beneath Bruch’s
membrane. This slab, referred to as the outer retina to
choriocapillaris (ORCC) slab, should contain both type 1 and
type 2 CNV.10,17 Removal of the retinal projection artifacts
from overlying retinal vasculature onto the ORCC slab was
performed as previously described.10,15–17 The en face ORCC
slab flow image following projection artifact removal was
displayed as a grayscale image for grading each neovascular
lesion’s area.
To be included in this study, the CNV had to be entirely
contained within the 33 3-mm2 en face ORCC slab flow image
obtained from both the SS-OCTA and SD-OCTA datasets. In
addition, images had to have a signal strength of at least six
without the presence of excessive motion artifacts. The images
were assembled randomly into two datasets of 333-mm2 scans
and 6 3 6-mm2 scans. Two graders (JROD and ZY) outlined
each neovascular lesion using Adobe Photoshop Creative
Cloud (Release 2015.1.2; Adobe Systems, Inc., San Jose, CA,
USA) and a Wacom pen tablet (Wacom Technology Corpora-
tion, Portland, OR, USA). Graders outlined the images in two
sessions. They were masked as to which instrument was used
to acquire the image. If the graders felt that no neovascular
lesion could be clearly demarcated, then no image was
outlined. After grading the images separately, the graders
reached a consensus outline for each image, and if any
lingering disagreements persisted, the senior grader (PJR)
adjudicated the case. None of the graders reviewed the images
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prior to grading. Training of graders was performed using
OCTA images from both instruments that were not included in
the final grading. Pixel counts from the outlined area were
measured using Adobe Photoshop, and the pixel counts were
converted into area measurements.
Lesion areas obtained using the SD-OCTA and SS-OCTA
datasets, as well as Bland-Altman analyses for the differences in
area measurements, are reported. Statistical analysis was
performed with IBM SPSS Statistics for Windows, Version
22.0 (IBM Corporation, Armonk, NY, USA).
RESULTS
Comparing Measurements of CNV Between Two
Devices
One hundred fifteen eyes from 90 patients with nvAMD were
imaged as described above. Thirty-five eyes were excluded
because the CNV was not fully contained within the 333-mm2
scan area. An additional 53 eyes were excluded because of
signal quality problems with at least one of the four scans,
which included scans with signal strength below six or
excessive motion artifacts.
Twenty-seven eyes from 23 patients with neovascular AMD
imaged from October 2015 to April 2016 were identified as
candidates for this study. Thirteen (56%) of the 23 patients
were men. Mean patient age was 77.4 years old and ranged
from 51 to 88 years old. At the time of imaging, 25 of 27 eyes
had received prior intravitreal therapy with VEGF inhibitors, 1
eye received an injection on the day of imaging due to new
onset exudation, and 1 eye had CNV without exudation and
was being observed as previously described.10
Of the 108 images outlined by the graders, only one image
needed adjudication by the senior grader. Neovascular lesions
were identified in all 333-mm2 images from both the SD-OCTA
and SS-OCTA instruments. However, in four 63 6-mm2 images,
one SS-OCTA scan and three SD-OCTA scans, the graders could
not outline a neovascular lesion, resulting in area measure-
ments equal to 0 mm2.
Overall, the area measurements obtained from the SS-OCTA
instrument were significantly larger than the area measure-
ments from the SD-OCTA instrument for the 333-mm2 and 63
6-mm2 scans, and this difference was more pronounced for the
63 6-mm2 scans. Mean area measurements for the 33 3-mm2
scans from the SS-OCTA and SD-OCTA instruments were 1.17
and 1.01 mm2, respectively (P ¼ 0.047). Mean area measure-
ments for the 636-mm2 scans from the SS-OCTA and SD-OCTA
instruments were 1.24 and 0.74 mm2 (P ¼ 0.003). Figure 1
shows an example of a neovascular lesion that had similar area
measurements with both the SD-OCTA and SS-OCTA instru-
ments. Figure 2 shows an example of a neovascular lesion that
had a larger area measurement with the SS-OCTA instrument
compared with the SD-OCTA instrument. Figure 3 is an
example of a nonexudative neovascular lesion in which the
quiescent lesion could be imaged using the 3 3 3-mm2 scan
from both instruments, with a larger measurement arising from
the SS-OCTA scan, but this neovascular lesion could not be
adequately imaged using the SD-OCTA instrument’s 63 6-mm2
scan. As seen in the examples, the major differences in the area
measurements occurred at the margins of the lesions.
Measurements from the SD-OCTA and SS-OCTA scans are
compared in the scatter plots shown in Figure 4 and the Bland-
Altman analyses shown in Figure 5. Overall, the hand-drawn
area measurements were larger for the SS-OCTA scans, and this
was particularly obvious for the 6 3 6-mm2 scans with a
number of eyes showing larger area measurements on SS-OCTA
imaging compared with the 3 3 3-mm2 scans (Figs. 4, 5).
FIGURE 1. En face SS- and SD-OCTA images from the left eye of a 70-
year-old woman with CNV secondary to AMD. All images were
processed from the corresponding volumetric datasets using the same
algorithms that were applied to a slab that extended from the outer
retina to the choriocapillaris and included the removal of the
projection artifacts from the retinal vasculature. (A) Swept-source
OCTA 333-mm2 scan. (B) Swept-source OCTA 333-mm2 scan with an
outline of the CNV and an area of 1.51 mm2. (C) Spectral-domain OCTA
3 3 3-mm2 scan. (D) Spectral-domain OCTA 3 3 3-mm2 scan with an
outline of the CNV and an area of 1.51 mm2. (E) Swept-source OCTA 6
3 6-mm2 scan. (F) Swept-source OCTA 63 6-mm2 scan with an outline
of the CNV and an area of 1.52 mm2. (G) Spectral-domain OCTA 63 6-
mm2 scan. (H) Spectral-domain OCTA 63 6-mm2 scan with an outline
of the CNV and an area of 1.13 mm2. In this example, the area
measurements were similar for the 3 3 3-mm2 scans, but SS-OCTA
imaging showed a larger lesion for the 63 6-mm2 scans.
Imaging of CNV With SS-OCTA and SD-OCTA IOVS j March 2017 j Vol. 58 j No. 3 j 1501
Downloaded from iovs.arvojournals.org on 05/10/2019
FIGURE 2. En face SS- and SD-OCTA images from the left eye of an 87-
year-old woman with CNV secondary to AMD. All images were
processed from the corresponding volumetric datasets using the same
algorithms that were applied to a slab that extended from the outer
retina to the choriocapillaris and included the removal of the
projection artifacts from the retinal vasculature. (A) Swept-source
OCTA 333-mm2 scan. (B) Swept-source OCTA 333-mm2 scan with an
outline of the CNV and an area of 1.25 mm2. (C) Spectral-domain OCTA
3 3 3-mm2 scan. (D) Spectral-domain OCTA 3 3 3-mm2 scan with an
outline of the CNV and an area of 0.722 mm2. (E) Swept-source OCTA 6
3 6-mm2 scan. (F) Swept-source OCTA 63 6-mm2 scan with an outline
of the CNV and an area of 1.40 mm2. (G) Spectral-domain OCTA 63 6-
mm2 scan. (H) Spectral-domain OCTA 63 6-mm2 scan with an outline
of the CNV and an area of 0.535 mm2. In this example, SS-OCTA
imaging yielded the larger area measurements for both the 33 3- and 6
3 6-mm2 scans compared with SD-OCTA imaging.
FIGURE 3. En face SS- and SD-OCTA images from the left eye of a 79-
year-old man with CNV secondary to AMD. All images were processed
from the corresponding volumetric datasets using the same algorithms
that were applied to a slab that extended from the outer retina to the
choriocapillaris and included the removal of the projection artifacts
from the retinal vasculature. (A) Swept-source OCTA 33 3-mm2 scan.
(B) Swept-source OCTA 333-mm2 scan with an outline of the CNV and
an area of 1.75 mm2. (C) Spectral-domain OCTA 33 3-mm2 scan. (D)
Spectral-domain OCTA 33 3-mm2 scan with an outline of the CNV and
an area of 1.60 mm2. (E) Swept-source OCTA 6 3 6-mm2 scan. (F)
Swept-source OCTA 636-mm2 scan with an outline of the CNV and an
area of 1.95 mm2. (G) Spectral-domain OCTA 6 3 6-mm2 scan. (H)
Spectral-domain OCTA 63 6-mm2 scan without any outline of the CNV
due to the consensus between graders that the lesion borders for the
CNV were not clearly demarcated.
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Moreover, the 3 3 3-mm2 scans showed a much better
correlation between the area measurements from the two
instruments (r ¼ 0.84, P < 0.001) compared with the 6 3 6-
mm2 scan measurements (r ¼ 0.33, P ¼ 0.093). In addition,
larger differences in area measurements were associated with
larger lesions (Fig. 5).
Comparing Contrast-to-Noise Between Two
Devices
Image quality can play an important role when the ORCC
angiograms are compared. We hypothesized that the better
light penetration, sensitivity, and scan density of the SS-OCTA
images should result in better image quality for the OCTA
ORCC angiograms, which should lead to more reliable
measurements of CNV. To test this hypothesis, we compared
the image quality of the ORCC angiograms delivered by SD-
OCTA and SS-OCTA using the contrast-to-noise ratio (CNR).
Contrast-to-noise ratio is similar to the signal-to-noise ratio, but
subtracts off a term corresponding to the noise background
before taking the ratio. This is important when there is a
significant bias in an image, such as nonzero mean noise
background, which is true for OCT images. In the evaluation,
we defined CNR as follows18:
CNR ¼ jls  lnj
r
where ls is the signal mean; ln is the mean of the background
noise; and r is the standard deviation of the background noise.
After the calculation of CNRs for all the ORCC angiograms
obtained from the enrolled eyes, we performed a subgroup
analysis between the devices and between the fields of view.
We found that the mean values of CNR for the 333-mm2 scans
are 2.42 and 2.08 for the SS-OCTA– and SD-OCTA–derived
ORCC angiograms, respectively, and for the 63 6-mm2 scans,
the mean values of the CNR are 1.96 and 1.12 for the SS-OCTA–
FIGURE 4. Scatter plots comparing area measurements of CNV obtained using 3 3 3- and 6 3 6-mm2 SS- and SD-OCTA scans. (A) Comparison
between 33 3-mm2 CNV area measurements from the SS-OCTA and SD-OCTA instruments. Slightly larger CNV areas were measured using the SS-
OCTA instrument (P ¼ 0.047), but the correlation coefficient was good at r ¼ 0.84 (P < 0.001). (B) Comparison between 6 3 6-mm2 CNV area
measurements from the SS-OCTA and SD-OCTA instruments. Larger CNV areas were measured using the SS-OCTA instrument (P¼ 0.003), and the
correlation coefficient was modest at r ¼ 0.33 (P¼ 0.093).
FIGURE 5. Bland-Altman plots showing the difference in area measurements of CNV obtained using SS- and SD-OCTA scans with both the 333- and
6 3 6-mm2 scan patterns. (A) Difference in area measurements between SS-OCTA and SD-OCTA imaging using the 3 3 3-mm2 scan and the
relationship with mean lesion area. (B) Difference in area measurements between SS-OCTA and SD-OCTA imaging using the 636-mm2 scan and the
relationship with mean lesion area.
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and SD-OCTA–derived ORCC angiograms, respectively. The
comparison is summarized in the Table. Significantly higher
CNR values were found in both the fields of view for SS-OCTA
images, indicating that SS-OCTA has the capability to deliver
ORCC angiograms with better image quality compared with
SD-OCTA.
DISCUSSION
Both SS-OCTA and SD-OCTA imaging can detect CNV, but SS-
OCTA detects on average a larger area for the CNV than
detected using SD-OCTA imaging. Whether the actual CNV is
even larger than the area detected by SS-OCTA remains to be
determined, but in our previous report describing indocya-
nine green angiography (ICGA) imaging of nonexudative CNV
in AMD, we found that the SS-OCTA images were comparable
to the size and configuration of the plaques identified on
ICGA imaging.10 The results presented in this current report
indicate that en face SS-OCTA imaging provided a more
accurate representation of the CNV compared with SD-OCTA
imaging, in particular the SS-OCTA measurements are more
consistent across the different scan sizes. The area measure-
ments on SS-OCTA imaging were larger for both the 3 3 3-
mm2 scans (P¼ 0.047) and the 63 6-mm2 scans (P¼ 0.003).
The difference in lesion areas was much larger for the 63 6-
mm2 scans than the 333-mm2 scans. The higher variability in
the measurements obtained with the 6 3 6-mm2 scans
compared with the 3 3 3-mm2 scans, is consistent with the
CNR reported above. We found that the angiograms from the
33 3-mm2 scans provided a higher CNR compared with that
of 63 6-mm2 scans. The lower CNR values for the 63 6-mm2
scans might be attributed to two reasons: the pixel spacing
was larger than in the 33 3-mm2 scans (14.3 vs. 10 lm for SS-
OCTA and 17.1 vs. 12.2 lm for SD-OCTA) and the repetition
numbers of B-scans at one spatial location was lower than in
the 333-mm2 scans (2 vs. 4). The lower CNR values for 636-
mm2 scans is likely responsible for the observed limitations in
the reproducibility of CNV measurements. It is important to
note that the CNR values of 1.96 for the SS-OCTA 63 6-mm2
scan is close to that of 2.08 for SD-OCTA 3 3 3-mm2 scan,
despite using only two repeated B-scans to obtain the OCT
angiographic signals (instead of four). Although we were
unable to control for the scanning densities used in both
instruments, our analysis of the CNR values would suggest
that the higher scanning densities used in SS-OCTA imaging
contributed to its superior detection of CNV compared with
SD-OCTA imaging. Moreover, the superiority of SS-OCTA
detection of CNV using a 6 3 6-mm2 scan pattern has real-
world clinical relevance given the fact that CNV routinely
extends outside the central 3 3 3-mm2 scan pattern, and
identifying the full extent of the CNV would be important for
the detection and follow-up of these lesions.
Previously, Novais et al.9 compared the visualization of CNV
in nvAMD using both SD-OCTA and SS-OCTA; however, they
used different segmentation strategies when analyzing the
images from each instrument. Because we know that
segmentation boundaries greatly influence the ability to
visualize the entire CNV, we felt it was necessary to repeat
their study using the same segmentation strategy. To achieve
these objectives, the SD-OCTA and SS-OCTA datasets were
downloaded directly from the instruments and processed using
custom application software.8,10,14–16 Our study used the same
OMAG algorithm to generate the decorrelation signals, the
same algorithm to generate the segmentation boundaries, and
the same algorithm for the removal of the retinal vessel
projection artifacts.
Limitations of our study include a small sample size, the use
of segmentation and image processing strategies that were not
commercially available at this time, and the need to exclude a
large number of eyes, either because the CNV was not entirely
contained in a 3 3 3-mm2 scan or because of problems with
scan quality. The requirement for all the scans to be of the
highest image quality and the exclusion of poor quality scans
was intended to allow for the best possible quantitative
comparison between instruments, but many of the images
would have sufficed in the routine clinical care of patients
when qualitative assessment of CNV was all that was needed.
Overall, there were no differences between instruments with
respect to signal strength and motion artifacts. In addition, we
only examined lesions fully contained within the 3 3 3-mm2
scan to obtain a sample where the two scan sizes could be fully
compared and a possible difference in performance based on
the different scanning densities could be assessed. One reason
for decreased signal strength appeared to be the presence of a
cataract; however, a more detailed study is needed to address
the imaging of CNV through cataracts using the different
devices.
Given the findings previously reported by Novais et al.,9 it
should come as no surprise that SS-OCTA imaging was better at
detecting CNV than SD-OCTA imaging. This ability to detect
the presence and size of CNV through an intact RPE should
prove particularly useful in eyes with nonexudative AMD in
which CNV is present but macular fluid is absent.10,19,20 More
significantly, there is speculation that the portion of the
neovascular lesion that might need to be visualized to predict
future growth and exudation is the region at the borders of the
lesion, and it is this border region that SS-OCTA is better at
visualizing than SD-OCTA imaging. In addition, when using
OCTA to follow eyes with exudative CNV to determine when
retreatment might be needed, the ability to detect the entire
lesion and changes at the borders of the lesion could very well
influence the retreatment decision.
Previously, De Carlo et al.12 reported a specificity of 91%
but a sensitivity of only 50% for detecting CNV using SD-OCTA.
Most likely, SS-OCTA imaging would have a significantly better
sensitivity. The improved detection of CNV by SS-OCTA also
raises an interesting question about the current and future gold
standard for imaging CNV. Given the shorter time of
acquisition, lower cost of acquisition, greater convenience,
greater comfort, and greater safety of imaging with OCTA
compared with dye-based angiography, it is just a matter of
time before SS-OCTA becomes the gold standard for imaging
CNV. The greatest limitations for the widespread use of this
imaging technique are the high cost of purchasing the
instruments and the availability of the instruments, but these
TABLE. Comparison Between CNR Values of SS-OCTA– and SD-OCTA–Derived ORCC Angiograms
CNR
3 3 3-mm2 Scans 6 3 6-mm2 Scans
SD-OCTA SS-OCTA SD-OCTA SS-OCTA
Mean (minimum, maximum) 2.08 (0.94, 4.93) 2.42 (0.91, 4.89) 1.12 (0.35, 2.53) 1.96 (0.87, 3.13)
Standard deviation 0.90 0.96 0.56 0.58
P value 0.008 <0.001
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limitations should be resolved in the very near future.
Moreover, with increasing scanning rates, which will result in
larger scan areas with higher sampling densities, and with
better tracking software on the horizon, we anticipate that the
upper limit for detection of CNV has not yet been achieved.
In summary, when using the instruments and algorithms
described in this report, we found that SS-OCTA imaging was
able to detect CNV better than SD-OCTA imaging. Although the
algorithms used in this study are not yet commercially
available, they are currently being developed for commercial
application and should be available in the very near future.
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